Quantcast

Latest Clinical research Stories

2014-10-21 16:28:41

First-Ever Product Submission for LAL Deficiency LEXINGTON, Mass., Oct. 21, 2014 /PRNewswire/ -- Synageva BioPharma Corp. (Synageva) (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, announced today the start of a rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for sebelipase alfa as a treatment for patients with lysosomal acid lipase deficiency (LAL Deficiency), a rare genetic...

2014-10-21 16:27:47

LONDON, Oct. 21, 2014 /PRNewswire/ -- Executive SummaryChina's regulatory framework for medical devices is undergoing radical changes. The country's new leaders have recognized that the regulations for supervision and administration of medical devices are far from perfect along with rapid population growth and thriving economy over the past 30 years. Chinese state council issued the latest "Regulations for the Supervision and Administration of Medical Devices" on February 12, 2014,...

2014-10-21 12:32:05

COSTA MESA, Calif., Oct. 21, 2014 /PRNewswire-iReach/ -- WCCT Global, a full service contract research organization headquartered in Southern California announced today the launch of a clinical trial patient recruitment rescue program for companies that are struggling to enroll their trials as the year comes to an end. WCCT Global's patient recruitment division "In-Site" is comprised of 12 key elements to ensure patient enrollment and retention. The rescue program that was effective...

2014-10-21 08:39:50

eCTD Accelerator - Templates, the only actively maintained eCTD template system is now available for immediate download. WARNER ROBINS, Ga., Oct. 21, 2014 /PRNewswire/ -- Today in Atlanta, GA, Aquila Solutions, LLC announced the immediate availability of eCTD Accelerator - Templates, enabling sponsors and consultants to dramatically reduce the cost of authoring drug and biologic applications in the eCTD format that is required by the US FDA and other countries. Joshua Boutwell,...

2014-10-21 08:35:08

MENLO PARK, Calif., Oct. 21, 2014 /PRNewswire/ -- SRI Biosciences, a division of SRI International, has completed construction of an early-phase clinical trial facility in Plymouth, Michigan. The 9,400-square foot unit, located in the Michigan Life Science Innovation Center, is now open and fully equipped for early-stage human research studies of new medicines and medical devices. "SRI International's newest facility in Michigan means great news ahead--groundbreaking discoveries,...

2014-10-21 08:35:03

? eClinical Innovations to Be Showcased in San Diego, Barcelona, and Orlando ? NEWTOWN, Pa., Oct. 21, 2014 /PRNewswire/ -- BioClinica®, Inc., a leading provider of outsourced clinical trial services and eClinical Solutions, today announced details of upcoming "Trial Blazer" User Conferences expected to draw hundreds of clinical trial professionals to exclusive customer events in Europe and the US. http://photos.prnewswire.com/prnvar/20130403/PH87647LOGO The first of these events will be...

2014-10-21 08:33:30

Universal needle-free reconstitution and transfer system now available for use in hospitals EXTON, Pa., Oct. 21, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the Vial2Bag® DC device from the United States Food and Drug Administration, and also the CE Mark for the European Union. http://photos.prnewswire.com/prnvar/20131029/NE05658LOGO The Vial2Bag...

2014-10-20 23:09:15

On October 10, the FDA advised consumers not to purchase or use Sit and Slim II due to hidden drug ingredients. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) October 20, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Sit and Slim II. The FDA advised consumers on October 10 not to purchase or use Sit...

2014-10-20 23:07:08

CDISC is pleased to announce an extensive update to the CDISC Business Case for the use of global, consensus-based standards for clinical research data and related areas of healthcare.CDISC standards at project initiation can save 70 - 90% of time and resources spent prior to first patient enrolled and approximately 75% of the non-patient participation time during the Study Conduct and Analysis stages. Austin, Texas (PRWEB) October 20, 2014 The Clinical Data Interchange Standards...

2014-10-20 08:33:33

LONDON, October 20, 2014 /PRNewswire/ -- Richmond Pharmacology has extended its capacity with an additional six-bed facility dedicated to screening and out-patient procedures for early phase studies in patients, complementing its existing 68-bed facility within Croydon University Hospital. (Photo: http://photos.prnewswire.com/prnh/20141013/709417-a ) (Photo: http://photos.prnewswire.com/prnh/20141013/709417-b ) The new facility is adaptable to...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related